Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cottone

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel DiseasePaolo Gionchetti, Fernando Rizzello, Vito Annese, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2018
Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2Fabio Salvatore Macaluso, Maria Cappello, Enrica Giuffrida, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2018
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysisSara Renna, Filippo Mocciaro, Marco Ventimiglia, et al.
Journal of Gastroenterology and Hepatology|May 20, 2020
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's diseaseFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitisFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Drugs & Aging|February 5, 2020
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)Serena Porcari, Anna Viola, Ambrogio Orlando, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel DiseasePaolo Gionchetti, Fernando Rizzello, Vito Annese, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2018
Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2Fabio Salvatore Macaluso, Maria Cappello, Enrica Giuffrida, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2018
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysisSara Renna, Filippo Mocciaro, Marco Ventimiglia, et al.
Journal of Gastroenterology and Hepatology|May 20, 2020
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's diseaseFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitisFabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Drugs & Aging|February 5, 2020
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)Serena Porcari, Anna Viola, Ambrogio Orlando, et al.
Pageof 12